Alirocumab (anti-PCSK9) [1245916-14-6]
HY-P9928A
Product group Antibodies
Overview
- SupplierMedChem Express
- Product NameAlirocumab (anti-PCSK9) [1245916-14-6]
- Delivery Days Customer10
- CAS Number1245916-14-6
- CertificationResearch Use Only
- ClonalityMonoclonal
- Estimated Purity98.24
- Scientific DescriptionAlirocumab (anti-PCSK9) is an anti-PCSK9 human monoclonal antibody. Alirocumab (anti-PCSK9) inhibits PCSK9. Alirocumab (anti-PCSK9) reduces NLRP3 inflammasome, regulates Nrf2/HO-1, HMGB1/NF-kappaB and Fractalkine/CX3CR1. Alirocumab (anti-PCSK9) increases the ability of the liver to bind LDL-cholesterol (LDL-C) and reduces levels of LDL-C in blood. Alirocumab (anti-PCSK9) improves atherosclerosis and inflammation[1][2][3][4][5][6][7][8][9][10][11].
- Storage Instruction-80°C
- UNSPSC41116161